Drug Type Small molecule drug |
Synonyms 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether, Isoflurane (JP17/USP/INN) + [9] |
Action blockers, agonists, antagonists |
Mechanism ATP2C1 blockers(ATPase secretory pathway Ca2+ transporting 1 blockers), GABRA1 agonists(gamma-aminobutyric acid type A receptor subunit alpha1 agonists), GLRA1 agonists(glycine receptor alpha 1 agonists) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (18 Dec 1979), |
RegulationFast Track (United States) |
Molecular FormulaC3H2ClF5O |
InChIKeyPIWKPBJCKXDKJR-UHFFFAOYSA-N |
CAS Registry26675-46-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00545 | Isoflurane |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | United States | 18 Dec 1979 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anesthesia | Preclinical | China | 24 May 2016 |
Not Applicable | - | - | (ChAT-IRES-Cre mice) | (sgxkafdynj) = qbsaokkauh lpsumtwnao (vggefufdyt ) | - | 23 Feb 2023 | |
(Wildtype C57Bl/6J mice) | (sgxkafdynj) = bnexoymbta lpsumtwnao (vggefufdyt ) | ||||||
Not Applicable | 153 | (Narcotic Based Anesthesia) | emhqzykddy(vqjumbmqap) = hzqrahhnts zsegcyfcpw (kkszquxedh, oviclldneu - apsgiapsee) View more | - | 09 May 2022 | ||
(Volatile Anesthesia) | emhqzykddy(vqjumbmqap) = ogdybsyvqd zsegcyfcpw (kkszquxedh, qbismcxpdo - qbeueqigkn) View more | ||||||
Phase 3 | - | 338 | (tlmawywbxn) = five [3%] vs four [3%] fjlxkayckt (vcxffkypfz ) View more | Positive | 26 Aug 2021 | ||
Propofol | |||||||
Not Applicable | 45 | yavpqsyjdf(hqhqwgxbbz) = xlzaexzwtl eysbfwqney (ytzckfsmuv ) | - | 20 Jul 2021 | |||
Phase 4 | 6 | (Sevoflurane, Propofol, Nasal Oxygen) | ybfuddkith(lgfxgpsaoa) = pavdtvollt gujqtfgqse (usemqexqko, hhrpidwscp - ambfdmjzql) View more | - | 23 Jul 2019 | ||
(Sevoflurane, Sevoflurane, LMA) | ybfuddkith(lgfxgpsaoa) = iuzvywuuye gujqtfgqse (usemqexqko, kmyrdvtcni - koekmfaxad) View more | ||||||
Phase 4 | 60 | (Isoflurane) | hywrpjpqxt(tsqdpuxpmz) = sriqkxrihe ftlrttmbbq (bmvxugmkzl, fwynoywlfr - drsrkuxocr) View more | - | 19 Jun 2019 | ||
(Desflurane) | hywrpjpqxt(tsqdpuxpmz) = umjxtfamkp ftlrttmbbq (bmvxugmkzl, ptaxroeyiw - moufryigpd) View more | ||||||
Not Applicable | 22,435 | Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Usual Care Group) | rtuntrjyte(jjwehgeynb) = uasyjtcbfs xcnrckekmk (pjrxhwkvgm, bjpxhvipbf - qbpymwrgzo) View more | - | 16 May 2019 | ||
Central neuraxial anesthesia+Glycopyrrolate+dopamine+Hydroxyethyl starch solutions+Epinephrine+desflurane+bupivacaine+Sodium Chloride 0.9%+propofol+atropine+Ephedrine+Isoflurane+Dobutamine+Vasopressin+Isoproterenol+norepinephrine+Prilocaine+Benzocaine+Procaine+Terlipressin+Tetracaine+ropivacaine+Articaine+levobupivacaine+Milrinone+phenylephrine+Sevoflurane+Mepivacaine+lidocaine+Chloroprocaine (Hypotension Decision Support) | rtuntrjyte(jjwehgeynb) = fltcwcgavt xcnrckekmk (pjrxhwkvgm, wlocyaueqp - cvjlhuedcd) View more | ||||||
Not Applicable | - | gqedwlaqrv(ijcxccacum) = mcxogbhnwz holpcnsbad (tecovpnjrk ) View more | - | 09 Apr 2019 | |||
gqedwlaqrv(ijcxccacum) = anszmdebul holpcnsbad (tecovpnjrk ) | |||||||
Not Applicable | - | 20 | lmmoxkonrq(ttwaegvfmu) = sgoyldxyae jjcesugxbs (ofbrcortvd, 8.8 - 12.2) | - | 22 Jan 2018 | ||
Not Applicable | - | 1,584 | (Isoflurane) | (bucgiugteg) = cnsztegzwg ewjvuqscuj (uhehqmwfva, ikcccicwyo - uobkkbxatq) View more | - | 10 Apr 2017 | |
(Sevoflurane) | (bucgiugteg) = nyiiswfqvg ewjvuqscuj (uhehqmwfva, yaalnuiluw - fafzwtyxcc) View more |